These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36356117)

  • 1. Genetic testing for familial hypercholesterolaemia: utility beyond diagnosis.
    Bigossi M; Siddiqui MK
    Eur J Prev Cardiol; 2024 May; 31(7):e59-e61. PubMed ID: 36356117
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?
    Humphries SE; Norbury G; Leigh S; Hadfield SG; Nair D
    Curr Opin Lipidol; 2008 Aug; 19(4):362-8. PubMed ID: 18607183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
    Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N
    Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
    Wald DS; Wald NJ
    J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental attitude towards genetic testing for familial hypercholesterolaemia in children.
    Umans-Eckenhausen MA; Oort FJ; Ferenschild KC; Defesche JC; Kastelein JJ; de Haes JC
    J Med Genet; 2002 Sep; 39(9):e49. PubMed ID: 12205119
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan D;
    Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936
    [No Abstract]   [Full Text] [Related]  

  • 10. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?
    Paynter NP; Ridker PM; Chasman DI
    Circ Res; 2016 Feb; 118(4):607-19. PubMed ID: 26892961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolemia--we must act boldly.
    Moodie D
    Congenit Heart Dis; 2014; 9(4):273-4. PubMed ID: 25099345
    [No Abstract]   [Full Text] [Related]  

  • 12. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutation screening in patients for familial hypercholesterolaemia (ADH).
    Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G
    Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid testing for three mutations causing familial defective apolipoprotein B100 in 562 patients with familial hypercholesterolaemia.
    Talmud PJ; Tamplin OJ; Heath K; Gaffney D; Day IN; Humphries SE
    Atherosclerosis; 1996 Aug; 125(1):135-7. PubMed ID: 8831935
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethnic access to child-parent screening for familial hypercholesterolaemia.
    Wald DS; Bestwick JP
    Eur J Prev Cardiol; 2019 Aug; 26(12):1341-1342. PubMed ID: 30971125
    [No Abstract]   [Full Text] [Related]  

  • 17. People at risk of familial hypercholesterolaemia should have DNA test, says NICE.
    BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic testing for a patient with suspected familial hypercholesterolaemia.
    Mudgundi V; Williams G; Manou K; Block R
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30030251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE
    Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A family-based strategy for diagnosing familial hypercholesterolemia].
    Leren TP; Manshaus T; Ose L
    Tidsskr Nor Laegeforen; 2004 May; 124(9):1228-9. PubMed ID: 15131703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.